- Preview Available
- Scholarly Journal
The anti-VLA-4 antibody natalizumab induces erythroblastaemia in the majority of the treated patients with multiple sclerosis
Robier, Christoph; Amouzadeh-Ghadikolai, Omid; Bregant, Claudia; Diez, Josef; Melinz, Klaus
; et al.
Multiple Sclerosis Journal; London Vol. 20, Iss. 9, (Aug 2014): 1269-1272.
DOI:10.1177/1352458514521307
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.